Caligan Partners LP — EXELIXIS INC EXEL: Quarterly 13F Position History
Caligan Partners LP has reported EXELIXIS INC (EXEL) on 13 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2023. As of Q1 2026, the position is sized at 1,553,262 shares ($66.6M market value, 4.71% of the equity book).
- 1,553,262Shares Held (Latest Filing)
- $66.6MReported Market Value (Latest Filing)
- 4.71%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$1.5MQuarter-over-Quarter Value Change
- 1,553,262Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 13 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,553,262 | 0 | — | $66.6M | 4.71% | $42.89 |
| Q4 2025 | 1,553,262 | +27,532 | +1.8% | $68.1M | 6.23% | $43.83 |
| Q3 2025 | 1,525,730 | 0 | — | $63.0M | 8.74% | $41.30 |
| Q2 2025 | 1,525,730 | 0 | — | $67.2M | 13.05% | $44.08 |
| Q1 2025 | 1,525,730 | 0 | — | $56.3M | 11.75% | $36.92 |
| Q4 2024 | 1,525,730 | 0 | — | $50.8M | 12.87% | $33.30 |
| Q3 2024 | 1,525,730 | 0 | — | $39.6M | 12.55% | $25.95 |
| Q2 2024 | 1,525,730 | +425,000 | +38.6% | $34.3M | 8.01% | $22.47 |
| Q1 2024 | 1,100,730 | +190,000 | +20.9% | $26.1M | 6.90% | $23.73 |
| Q4 2023 | 910,730 | 0 | — | $21.8M | 7.37% | $23.99 |
| Q3 2023 | 910,730 | 0 | — | $19.9M | 10.18% | $21.85 |
| Q2 2023 | 910,730 | +60,730 | +7.1% | $17.4M | 10.58% | $19.11 |
| Q1 2023 | 850,000 | — | — | $16.5M | 11.51% | $19.41 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Caligan Partners LP first disclose a EXEL position in 13F-HR filings?
Caligan Partners LP first reported EXELIXIS INC (EXEL) on its 13F-HR filing for the period ending 2023-03-31 (Q1 2023). The position has appeared on 13 reported quarters within Pactolio's tracked window.
What was Caligan Partners LP's most recent quarter-over-quarter share-count change in EXEL?
Caligan Partners LP held the same 1,553,262 shares of EXEL between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Caligan Partners LP's cost basis in EXEL?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.